Advertisement

Topics

Search Results for "Avesthagen Limited Cosmosid"

09:57 EDT 21st October 2017 | BioPortfolio

Matching Channels

PATHSEEK

Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

RPL554

Verona’s lead drug, RPL554, is a dual phosphodiesterase (PDE) 3 and 4 inhibitor being developed as a novel treatment for chronic obstructive airways disease as COPD (chronic obstructive pulmon...

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Coronavirus

Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronavir...

Matching News

Orange County Water District Leads National Science Foundation Funded Study of the Metagenomics of Water Quality

FOUNTAIN VALLEY, Calif., Sept. 6, 2017 /PRNewswire/ -- The Orange County Water District (OCWD; the District) is a recipient, with the University of Maryland and CosmosID, Inc., of a National Scie...

Avesthagen Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

SummaryAvesthagen Ltd Avesthagen is a life science company that offers preventive personalized healthcare solutions. The company offers bionutrition, bioagriculture and biopharmaceutical products. Its...

Avesthagen Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11072017] Prices from USD $250

SummaryAvesthagen Ltd Avesthagen is a life science company that offers preventive personalized healthcare solutions. The company offers bionutrition, bioagriculture and biopharmaceutical products. Its...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second qu...

Vical Announces that its Antifungal VL-2397 is Eligible for Limited Use Indication Approval by FDA Based on a Single Phase 2 Efficacy Trial

Vical plans to initiate Phase 2 trial of VL-2397 for the treatment of invasive aspergillosis in 4Q 2017 Management to host conference call on October 3rd at 12:00 pm ET to discuss the Phase 2 tri...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement